Effect of renin-angiotensin-aldosterone system inhibitors on Covid-19 patients in Korea.

Jungchan Park Seung-Hwa LeeSeng Chan YouJinseob KimKwangmo Yang

Published in: PloS one (2021)

RAAS inhibitor treatment did not appear to increase the mortality of Covid-19 patients compared with other antihypertensive drugs, suggesting that they may be safely continued in Covid-19 patients.

Keyphrases

sars cov
angiotensin ii
angiotensin converting enzyme
blood pressure
cardiovascular events
cardiovascular disease
drug induced